Editorial to the Special Issue Entitled "Imaging in Immunooncology"
Mol Imaging Biol
.
2022 Apr;24(2):177-180.
doi: 10.1007/s11307-022-01719-z.
Authors
Gilbert O Fruhwirth
1
,
Bettina Weigelin
2
3
,
Heike E Daldrup-Link
4
,
Vladimir Ponomarev
5
Affiliations
1
Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King's College London, London, UK.
2
Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
3
Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies,", University of Tuebingen, Tübingen, Germany.
4
Department of Radiology, Stanford University, Stanford, CA, USA.
5
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[email protected]
.
PMID:
35303206
PMCID:
PMC8983534
DOI:
10.1007/s11307-022-01719-z
No abstract available
Publication types
Editorial
Introductory Journal Article
MeSH terms
Diagnostic Imaging*
Grants and funding
P30 CA124435/CA/NCI NIH HHS/United States